By Rifan Muazin 
The foundation of Michael and Xio Caruso’s relationship was built on a pair of white lies, a detail that now serves as a lighthearted prologue to a much more harrowing shared history. In 2007, when the two first connected on Match.com, both felt the pressure to present a slightly polished version of themselves. Xio, then 45, listed her age as 43, while Michael, who was in the midst of a legal separation, described himself as already divorced. When they finally met in person, the truth came out almost immediately. The mutual confession didn’t drive them apart; instead, it fostered a sense of transparency and forgiveness that would define their bond. By November 2009, two years after their digital introduction, they were married, embarking on a life that they expected to be defined by retirement, travel, and family.
For nearly a decade, the Carusos lived out their plan. They relocated from Texas to New York to provide support for their aging parents, a move that reflected their shared values of caregiving and loyalty. Michael, a veteran who had retired from the Navy in 2008, transitioned into a career as a financial advisor, while Xio utilized her expertise as a 401(k) administrator and consultant. Their lives were stable and predictable until a mundane moment in January 2017 fundamentally shifted their trajectory. While performing a routine stretch against a doorframe, Michael felt a distinct tightness and a palpable lump beneath his right nipple.
Initially, Michael dismissed the discovery. Having had a benign lipoma—a fatty tissue deposit—removed from his abdomen in his 20s, he assumed this was merely a recurrence of a similar non-threatening condition. However, Xio’s intuition proved sharper. At her insistence, Michael sought a consultation with his primary care physician. The clinical response was immediate and sobering: he was sent for a mammogram and a subsequent biopsy. Despite the escalating medical intervention, the couple remained optimistic, even flying to Florida to visit Michael’s parents while awaiting the results. They were convinced the tests would confirm Michael’s self-diagnosis of a harmless fatty mass. That optimism shattered when the doctor called Michael in Florida with a life-altering revelation: "I’m sorry—you have stage 2 breast cancer."
The diagnosis of male breast cancer (MBC) is a rare occurrence, representing less than 1% of all breast cancer cases globally. According to the American Cancer Society, about 2,800 men are diagnosed with invasive breast cancer annually in the United States, compared to over 300,000 women. Because of its rarity, many men—and even some healthcare providers—lack the awareness necessary for early detection. For Michael, the diagnosis triggered an immediate investigation into his genetic profile. While it was known that his mother was a breast cancer survivor who carried the BRCA gene mutation, the family had never considered that the trait could be passed to her son. The tests, however, were definitive: Michael was positive for the BRCA2 mutation.
The BRCA2 gene is a tumor suppressor; when it is mutated, the body’s ability to repair DNA damage is compromised, significantly increasing the risk of various cancers. While much of the public discourse surrounding BRCA mutations focuses on female breast and ovarian cancers, men with the BRCA2 mutation face a lifetime risk of breast cancer of approximately 7% to 8%, a stark increase from the 0.1% risk in the general male population. Furthermore, these men are at an elevated risk for prostate and pancreatic cancers, making the diagnosis a multifaceted health crisis.
Further pathological analysis revealed that Michael’s cancer was "triple-positive." This clinical designation means the tumor was fueled by estrogen and progesterone (hormone receptor-positive) and also overexpressed the HER2 protein (human epidermal growth factor receptor 2). Triple-positive breast cancer is traditionally aggressive, but it also responds well to targeted therapies. To combat the disease, Michael underwent a unilateral mastectomy, a procedure that involved a significant incision from his armpit to the center of his chest to remove the affected breast tissue. This was followed by a grueling regimen of chemotherapy.
The physical toll of the treatment was profound. Michael’s schedule became a repetitive cycle of exhaustion and recovery. Infusions on Thursdays led to a total physical collapse by Saturday, leaving him unable to leave his bed. By Monday, he would regain just enough strength to function, only to face the next round of toxins days later. The side effects were comprehensive: hair loss, persistent nausea, insomnia, and "moon face"—a swelling caused by the high doses of steroids required to manage the chemo’s impact. Throughout this period, Xio transitioned from wife to primary caregiver, navigating the complexities of Michael’s medical needs while managing her own burgeoning anxieties.
By the spring of 2018, Michael was nearing the end of his chemotherapy. The couple began to look toward a future beyond the "cancer bubble," planning to finally enjoy a condominium they had purchased in Florida. However, the reprieve was short-lived. During a routine annual mammogram, Xio’s doctors identified an abnormality. Having lived with dense breast tissue and a history of benign lumps, Xio initially hoped for a repeat of her past experiences. But the biopsy confirmed the unthinkable: she also had breast cancer.
The irony of the situation was not lost on them. While Michael’s diagnosis was a rare statistical anomaly, Xio’s was a confirmation of the 1-in-8 statistic that defines female health. Her cancer was Stage 1 and non-aggressive, a diagnosis that typically carries a high survival rate and less invasive treatment options. Her medical team determined that chemotherapy would not be necessary. Given the choice between a localized lumpectomy or a more definitive mastectomy, Xio chose a bilateral mastectomy. Haunted by the ordeal Michael had just endured, she wanted to eliminate any possibility of a recurrence.
The psychological impact of their dual diagnoses was complex. As Xio prepared for her surgery in May 2018—timed to coincide with the end of Michael’s treatment—she found herself grappling with "survivor guilt." Because her treatment did not involve the visible ravages of chemotherapy, she felt that some observers viewed her cancer as "lesser." This highlights a common phenomenon in oncology where patients whose treatments are less physically taxing feel their emotional trauma is invalidated. "Mentally, I was destroyed," Xio recalled. "Cancer is cancer," regardless of the stage or the treatment protocol.
As both Michael and Xio entered remission, they recognized a new calling: advocacy. The lack of visibility for male breast cancer had nearly cost Michael his life, and they were determined to ensure other men didn’t make the same mistake of dismissing symptoms. They joined the Male Breast Cancer Global Alliance (formerly the Male Breast Cancer Coalition), an organization dedicated to education, outreach, and support for men navigating a "pink" world. Michael began speaking at health fairs, confronting the deep-seated stigmas that often prevent men from seeking care. One of the most persistent myths he encountered was the belief that breast cancer in men is linked to sexual orientation. By sharing his story as a Navy veteran and a husband, Michael worked to de-stigmatize the disease, emphasizing that "men have breasts, too," and therefore can get breast cancer.
The advocacy work of the Carusos is part of a larger movement to change the gendered language of breast cancer. For decades, the "pink ribbon" culture has been instrumental in raising billions for research, but it has inadvertently alienated men. Men with breast cancer often report feeling out of place in oncology waiting rooms decorated in pink or reading brochures addressed exclusively to "sisters" and "mothers." By advocating for more gender-neutral language and inclusive screening practices—especially for men with known genetic risks like BRCA2—the Carusos have contributed to a vital shift in the medical landscape.
Today, Michael and Xio have stepped back from the front lines of advocacy to focus on the life they fought to preserve. Now retired, they have embraced a lifestyle of travel and leisure, taking cruises and "living it up" as a testament to their survival. Michael remains profoundly grateful for Xio’s persistence in 2017; he acknowledges that without her push, he likely would have ignored the lump until the cancer reached a terminal stage.
Reflecting on their journey from a Match.com lie to a shared battle with a life-threatening illness, the Carusos see their marriage not as a victim of circumstance, but as a product of it. The "silver lining" of their dual diagnosis is the ironclad partnership it forged. They transitioned from individuals who fudged the truth on a dating profile to a "dynamic team" that propped each other up through the darkest chapters of their lives. Their story serves as a powerful reminder of the importance of genetic awareness, the necessity of self-advocacy, and the enduring strength of a bond tested by the ultimate adversity. In the face of a disease that affects millions, the Carusos found that while they were both patients, they were, above all, each other’s greatest supporters.
